4basebio (LON:4BB) Trading 1.8% Higher – Here’s Why

4basebio PLC (LON:4BB) was up 1.8% on Monday . The company traded as high as GBX 1,140 ($14.35) and last traded at GBX 1,140 ($14.35). Approximately 9 shares were traded during mid-day trading, a decline of 99% from the average daily volume of 845 shares. The stock had previously closed at GBX 1,120 ($14.09).

4basebio Price Performance

The company has a debt-to-equity ratio of 201.47, a current ratio of 2.73 and a quick ratio of 3.52. The company has a 50 day moving average of GBX 1,188.70 and a 200-day moving average of GBX 1,294.01. The company has a market capitalization of £143.47 million, a P/E ratio of -1,435.90 and a beta of 1.09.

4basebio Company Profile

4basebio is a specialist life sciences group focused on supplying therapeutic synthetic DNA for gene therapies and gene-based vaccines and providing solutions for effective and safe delivery of DNA/RNA based products to patients.

Our focus is the development of high quality, GMP grade synthetic DNA as well as non-viral nanoparticles which can efficiently and safely deliver fully functional genes to patients.